Pediatric road traffic injuries in Qatar: Evidence for a developmental stage approach to road safety

Rafael Consunji1, Shahnaz Malik1, Ayman El-Menyar1

  • 1Hamad Injury Prevention Program, Hamad Trauma Center, Hamad Medical Corporation, Doha, Qatar.

Qatar Medical Journal
|March 14, 2020
PubMed

Insights

Pediatric road traffic injuries in Qatar disproportionately affect older male adolescents, especially drivers. Improved safety measures and policies are crucial to reduce child road traffic deaths and injuries.

Area of Science:

  • Public Health
  • Traumatology
  • Pediatrics

Background:

  • Road traffic injuries are a leading cause of death in Qatar.
  • Epidemiology of pediatric road traffic injuries (pRTIs) in Qatar requires further description.

Purpose of the Study:

  • To describe the epidemiology of pediatric road traffic injuries in Qatar.
  • To understand relationships between risk factors, injury mechanisms, safety equipment use, and child developmental stages.

Main Methods:

  • Analysis of pediatric road traffic injury cases (0-18 years) from January 2010 to December 2012.
  • Data sourced from the Hamad Trauma Center trauma registry, including motor vehicle occupants, pedestrians, cyclists, motorcyclists, and all-terrain vehicle (ATV) users.

Main Results:

  • 9.1% of trauma patients were pRTIs (443 cases); 83% male, 71% non-Qatari.
  • Low restraint use (1.2% for passengers/drivers); overall mortality rate 3.4%.
  • Older adolescents (15-18 years) accounted for 56.4% of motor vehicle crash (MVC) mortality and 40% of all pRTI victims, despite being 17% of the pediatric population.

Conclusions:

  • Distinct age and mechanism-specific patterns of pRTIs exist in Qatar.
  • Targeted road safety policies for underage pedestrians and drivers are essential.
  • Interventions like increased restraint use and graduated driver licensing should be considered.

Related Concept Videos

Three Developmental Domains01:29

Three Developmental Domains

Human development is typically examined across three main domains: physical, cognitive, and socio-emotional. These domains represent the significant areas of change and continuity throughout the lifespan, from infancy to late adulthood.
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
853
Survey Safety01:28

Survey Safety

Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
332
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
198
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
185